Skip to main content
Signal8
Mayer Timothy profile photo

Timothy Mayer

CIK: 0001775460

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NextCure, Inc. logo
NXTC

NextCure, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • NextCure, Inc. logo
    NXTC

    NextCure, Inc.

    Jan 30, 2026
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    14.7K shares-
  • NextCure, Inc. logo
    NXTC

    NextCure, Inc.

    Jan 31, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    117.4K shares-

1-2 of 2

About Mayer Timothy

Mayer Timothy (SEC CIK 0001775460) files insider reports with the SEC as Chief Operating Officer of NextCure, Inc. (NXTC).

Signal8 holds 2 ownership filings by Mayer Timothy, all Form 4s, filed between Feb 3, 2025 and Feb 3, 2026. Those filings report 2 transactions, from Jan 31, 2025 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mayer Timothy's filings is in BELTSVILLE, MD.

Recent filings by Mayer Timothy

  • Jan 30, 2026: Grant or award of NXTC derivative securities (Form 4, code A).
  • Jan 31, 2025: Grant or award of NXTC derivative securities (Form 4, code A).

Other insiders filing for NextCure, Inc. (NXTC)

How to read Form 4 transaction codes